Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
2(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
13%
Ph not_applicable
7
88%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 3Large-scale testing
1(12.5%)
N/ANon-phased studies
7(87.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(2)
Completed(6)

Detailed Status

Completed6
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (12.5%)
N/A7 (87.5%)

Trials by Status

active_not_recruiting225%
completed675%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
PROCEDURE
Total Trials
8